Time-resolved fluorescence was applied to linear and branched pyrene-labelled macromolecules to study their internal dynamics. The linear macromolecules consisted of two series of pyrene-labelled poly(N-isopropylacrylamide)s where the polymer was either end-labelled (Py2-PNIPAM-Y where Y represents the molecular weight of the polymer and equals 6, 8, 14, 25, and 45 kDa) or randomly labelled (Py-PNIPAM-X% where X represents the pyrene content and is equal to 0.1, 2, 3, 4, 5, and 6 mol%) with pyrene. Four dendrimer generations based on a bis(hydroxymethyl)propionic acid backbone represented the branched macromolecules where the terminal sites were labelled with pyrene (PyX-GY-COOH where X represents the number of pyrene units incorporated into the Y`th generation dendrimer). A polystyrene-dendrimer hybrid was also synthesized (PyX-GY-PS). The fluorescence decays of the Py2-PNIPAM-Y and Py-PNIPAM-X% samples were acquired in solvents of varying viscosity and were analyzed with the Birks Scheme and the Fluorescence Blob Model (FBM) to yield the excimer formation rate constants and , respectively. The two parameters showed the same trends with varying viscosity, implying that the same information concerning chain dynamics is obtained from the randomly and end-labelled PNIPAM samples. The fluorescence decays of the Py2-PNIPAM-Y samples were acquired in ethanol and in water to determine how pyrene solubility affects the behavior of the polymers in solution, as probed by time-resolved fluorescence. It was found that the decreased pyrene solubility in water led to large amounts of intra- and intermolecular pyrene aggregation. Finally, the pyrene-labelled dendrimers were studied in tetrahydrofuran (THF) to probe the mobility of the chain ends as a function of generation number. The average rate of excimer formation, , obtained from the Model-Free analysis of the fluorescence decays in THF, increased linearly with generation number. This finding, combined with molecular mechanics optimizations, led to the conclusion that excimer formation was greatly enhanced due to the branched nature of the dendrimer molecule. Together, these studies illustrate three different applications of the use of time-resolved fluorescence to characterize the internal dynamics of pyrene-labelled macromolecules.

Šiame darbe naudojamas Epsilon potenciastato modelis, sujungtas su Epsilon EC-2000-XP(Ver. 1.40.67_NT) programa ir kompiuteriu. Tyrimo metu naudojama trijų elektrodų celė. Darbiniu ir pagalbiniu elektrodais naudojami platinos elektrodas. Palyginamuoju naudojamas Ag/AgCl/KClsot elektrodas. Visos potencialų vertės nurodomos palyginamojo elektrodo atžvilgiu. POT sluoksnis nusodintas potenciostatiniu ir potenciodinaminiu būdu ant platinos elektrodo, keičiant eksperimento sąlygas. Potenciodinaminiai dengimo matavimai atlikti keičiant elektrodo potencialą nuo -0,1V iki 1,0V ir nuo -0,1V iki 1,2V. Dengiant Pt elektrodą buvo atliekama 10 arba 20 ciklų. Potencialo skleidimo greitis – 10, 20, 50 ir 100 mV/s. Potenciostatiniai dengimo matavimai atlikti esant pastoviam potencialui Econst 0,9V, 1,0V ir 1,2V ir dengimo laikui (tdeng) 1, 3 arba 5 minutės. Poli(o-metilanilinu) modifikuoti elektrodai gali būti naudojami askorbo rūgšties analizei tirpaluose, kurių pH 5,5. Askorbo rūgšties koncentracijų intervale nuo 0,1mM iki 1mM gaunama tiesinė oksidacijos ribinių srovių priklausomybė nuo koncentracijos, jei askorbo rūgšties matavimai atliekami potenciostatinėmis sąlygomis. Žemiausia askorbo rūgšties nustatymo riba – 0,1mM. / The Epsilon potentiometer model combined with a PC running Epsilon EC-2000-XP (Ver. 1.40.67_NT) software was used in these theses. During the research, a three-electrode cell was used. A platinum electrode was utilised as the working and auxiliary electrode. An Ag/AgCl/KClsot electrode was used as reference electrode. All values of the potentials refer to this electrode. An POT layer was deposited under potentiostatic or potentiodynamic conditions on platinum electrode by varying parameters of the experiment. Potentiodynamic polymer formation measurements were performed by alternating the electrode potential from 0.1V to 1.0V and from 0.1V to 1.2V. When modifying Pt electrode, 10 or 20 potential cycles were performed. The potential scan rate was 10, 20, 50, and 100 mV/s. Potentiostatic polymer formation measurements were performed under the constant potential Econst 0.9V, 1.0V, and 1.2V, and the time of coating (tcoating) was 1, 3 or 5 minutes. Poly (o-methylaniline) modified electrodes can be used for the analysis of ascorbic acid in solutions with pH values 5,5. Within the concentration interval of ascorbic acid between 0,1mM and 1mM, a linear dependence between oxidation limit currents and concentration was observed when ascorbic acid measurements were carried out potentiostatic conditions. The lowest sensing limit of ascorbic acid was 0,1mM.

Darbe tirtos struktūrinės ir spektroskopinės dviejų šeimų nematinių skystakristalinių dendrimerų ištirpintų chloroforme savybės. Taip pat struktūrinės, spektroskopinės ir magnetooptinės dendrimerų su įterptomis Co nanodalelėmis savybės. Dviejų šeimų skystakristalinių dendrimerų ištirpintų chloroforme optiniai tyrimai parodė, kad pirmos šeimos skystakristalinių dendrimerų vidinę dalį nusakanti sugerties juosta antros ir penktos generacijų atžvilgiu yra paslinkusi per 8nm, tuo tarpu antros šeimos atitinkamai pirmos ir penktos generacijų atžvilgiu per 19nm. Dendrimerų su įterptomis Co nanodalelėmis magnetooptiniai tyrimai parodė, kad Co nanodalelės gali būti valdomos magnetiniais laukais. / Dendritic structure is one of the prevalent topologies on our planet [1]. Dendrimers is generally described as monodispersed low viscosity macromolecules with highly branched, well defined 3D structure, first reported in 1978 by Vögtle. They are always composed of a core molecule and dendritic branches extended from core to terminal groups [26]. The number of functional groups on the dendrimer surface increases exponentially as a function of generation, of that in the higher generations they become much more spherical and amplified highly ordered architectures. Liquid crystalline dendrimers of their unique structural and physical properties have attached considerable attention. Because of their hyper branched spherical structure, interior inside dendrimers have fixed cavities. Strong interaction forces in the terminal mesogenic units determine that in the interior can be incorporated atoms, ions, guest molecules or nanoparticles. They are particularly well suited materials for hosting nanoparticles of the following reasons: nanoparticles are stabilized and don’t agglomerate, dendrimer branches can be use as selective gates to control access of small molecules [19]. As result of their architecture, dendrimers can possess essential physical, chemical and biological properties and whole range of applications in energy, medicine, engineering, information technology and ect. We present optical and structural studies of liquid crystalline poly(propylene imine) (PPI) dendrimers... [to full text]

Mannose-binding lectin (MBL) and ficolins are complement-activating proteins, and both play an important role in innate immunity by recognizing specific carbohydrate moieties on the surface of wide range of microorganisms. Previous studies have shown that porcine ficolin-α and MBL-A bind to surface polysaccharides of bacteria cultured in suspension, but their interactions with bacteria in biofilm culture have not been studied. The objectives of this thesis were to determine whether porcine plasma ficolin and MBL bind to Actinobacillus pleuropneumoniae in biofilm cultures. APP serotype 5a (APP5a) was used because it produced pronounced biofilm in plastic culture dishes, in comparison with APP5b that was previously reported to bind ficolin in suspension cultures. N-acetylglucosamine (GlcNAc) in the biofilm produced by APP5a was stained with wheat germ agglutinin conjugated with Alexa Fluor-555 and identified by confocal laser scanning microscopy (CLSM). Dispersin B prevented APP5a biofilm formation indicating the requirement of poly N-acetylglucosamine (PNAG) for bacterial cohesion. Bound purified ficolin or ficolin in plasma both were eluted with GlcNAc from APP5a biofilm cultures. To address preferential binding of ficolin-α to biofilm matrix, ficolin-α was eluted with GlcNAc from extracellular polymeric substances (EPS) in supernatant after pelleting the bacteria. Biotinylated-ficolin that retained GlcNAc-binding activity for APP5b planktonic cultures was shown to bind strongly to APP5a biofilm, as detected by fluorescent NeutrAvidin staining and CLSM, but not in the presence of GlcNAc. Further, MBL-A in ficolin-depleted porcine plasma also bound to APP5a biofilm and was eluted with a sugar solution containing GlcNAc, galactose, mannose and glucose. These studies demonstrate that both porcine ficolin-α and MBL-A bind to biofilm cultures of APP5a in a carbohydrate-dependent manner, and suggest that the production of PNAG in biofilm is a binding target for ficolin. / Natural Sciences and Engineering Research Council of Canada (NSERC)

Plusieurs agents anticancéreux très puissants sont caractérisés par une solubilité aqueuse limitée et une toxicité systémique importante. Cette dernière serait liée d’une part à la solubilisation des agents anticancéreux à l’aide de surfactifs de bas poids moléculaire, connus pour leur toxicité intrinsèque, et d’autre part, par le manque de spécificité tissulaire des anticancéreux. Les vecteurs colloïdaux à base de polymères permettraient de résoudre certains défis liés à la formulation d’agents anticancéreux hydrophobes. D’abord, les polymères peuvent être sélectionnés afin de répondre à des critères précis de compatibilité, de dégradation et d’affinité pour le médicament à formuler. Ensuite, le fait d’encapsuler l’agent anticancéreux dans un vecteur peut améliorer son efficacité thérapeutique en favorisant son accumulation au niveau du tissu cible, i.e. la tumeur, et ainsi limiter sa distribution au niveau des tissus sains. Des travaux antérieurs menés au sein de notre laboratoire ont mené à la mise au point de micelles à base de poly(N-vinyl-pyrrolidone)-bloc-poly(D,L-lactide) (PVP-b-PDLLA) capables de solubiliser des agents anticancéreux faiblement hydrosolubles dont le PTX. Ce dernier est commercialisé sous le nom de Taxol® et formulé à l’aide du Crémophor EL (CrEL), un surfactif de bas poids moléculaire pouvant provoquer, entre autres, des réactions d’hypersensibilité sévères. Bien que les micelles de PVP-b-PDLLA chargées de PTX aient démontré une meilleure tolérance comparée au Taxol®, leur potentiel de ciblage tumoral et leur efficacité thérapeutique étaient similaires à la forme commerciale à doses égales. Ceci était possiblement dû au fait que les micelles étaient rapidement déstabilisées et ne pouvaient retenir leur cargo suite à leur administration intraveineuse. Nous avons donc décidé de poursuivre les travaux avec un autre type de vecteur, soit des nanoparticules, qui possèdent une stabilité intrinsèque supérieure aux micelles. L’objectif principal de cette thèse de doctorat était donc de mettre au point des nanoparticules polymères pour l’administration parentérale d’agents anticancéreux faiblement solubles dans l’eau. Les nanoparticules devaient permettre d’encapsuler des agents anticancéreux hydrophobes et de les libérer de manière contrôlée sur plusieurs jours. De plus, elles devaient démontrer un temps de circulation plasmatique prolongée afin de favoriser l’accumulation passive du médicament encapsulé au niveau de la tumeur. La première partie du travail visait à employer pour la première fois le copolymère amphiphile PVP-b-PDLLA comme émulsifiant dans la préparation de nanoparticules polymères. Ainsi, une méthode de fabrication des nanoparticules par émulsion huile-dans-eau a été appliquée afin de produire des nanoparticules à base de PDLLA de taille inférieure à 250 nm. Grâce aux propriétés lyoprotectrices de la couronne de PVP présente à la surface des nanoparticules, celles-ci pouvaient retrouver leur distribution de taille initiale après lyophilisation et redispersion en milieu aqueux. Deux anticancéreux hydrophobes, soit le PTX et l’étoposide (ETO), ont été encapsulés dans les nanoparticules et libérés de ces dernières de façon contrôlée sur plusieurs jours in vitro. Une procédure de « salting-out » a été appliquée afin d’améliorer le taux d’incorporation de l’ETO initialement faible étant donnée sa solubilité aqueuse légèrement supérieure à celle du PTX. Le second volet des travaux visait à comparer le PVP comme polymère de surface des nanoparticules au PEG, le polymère le plus fréquemment employé à cette fin en vectorisation. Par le biais d’études d’adsorption de protéines, de capture par les macrophages et de biodistribution chez le rat, nous avons établi une corrélation in vitro/in vivo démontrant que le PVP n’était pas un agent de surface aussi efficace que le PEG. Ainsi, malgré la présence du PVP à la surface des nanoparticules de PDLLA, ces dernières étaient rapidement éliminées de la circulation sanguine suite à leur capture par le système des phagocytes mononucléés. Par conséquent, dans le troisième volet de cette thèse, le PEG a été retenu comme agent de surface, tandis que différents polymères biodégradables de la famille des polyesters, certains synthétiques (PDLLA et copolymères d’acide lactique/acide glycolique), d’autres de source naturelle (poly(hydroxyalkanoates)(PHAs)), ont été investiguées comme matériaux formant le cœur des nanoparticules. Il en est ressorti que les propriétés physicochimiques des polyesters avaient un impact majeur sur l’efficacité d’encapsulation du PTX et son profil de libération des nanoparticules in vitro. Contrairement aux PHAs, les polymères synthétiques ont démontré des taux d’incorporation élevés ainsi qu’une libération contrôlée de leur cargo. Des études de pharmacocinétique et de biodistribution ont démontré que les nanoparticules de PDLLA dotées d’une couronne de PEG conféraient un temps de circulation plasmatique prolongé au PTX et favorisaient son accumulation tumorale. Les nanoparticules polymères représentent donc une alternative intéressante au Taxol®. / Many highly potent anticancer drugs are characterized by poor aqueous solubility and can impart significant systemic toxicity. This toxicity can be attributed in part to the solubilisation of these anticancer agents with low molecular weight surfactants that are known to cause serious biological side effects on their own. Moreover, following their intravenous (IV) injection, the anticancer agents distribute throughout the body, causing deleterious effects in healthy organs and tissues. Colloidal polymeric drug carriers have been investigated as a means to circumvent these drawbacks. First, polymeric materials can be tailored to meet specific requirements in terms of biocompatibility, biodegradability and affinity for the cargo molecule. Second, associating a drug to a carrier system can drastically alter its distribution throughout the body, enhancing its deposition at the target site, e.g. the tumour, while sparing healthy tissues, thus minimizing systemic toxicity. Previous work in our group has led to the design of block copolymer micelles based on poly(N-vinyl-pyrrolidone)-block-poly(D,L-lactide) (PVP-b-PDLLA) that were shown to solubilise hydrophobic anticancer agents such as paclitaxel (PTX). PTX is commercially available as Taxol®, a Cremophor EL (CrEL)-based formulation. CrEL is a low molecular weight surfactant that has been linked to severe side effects including life-threatening hypersensitivity reactions. Although PTX-loaded PVP-b-PDLLA micelles have demonstrated much improved tolerability compared to Taxol®, they did not increase PTX tumoral concentrations and exhibited anticancer efficacy similar to Taxol® at equivalent dosage. This was attributed to rapid destabilisation of the micelles and release of their cargo following IV administration. We chose to pursue our work with a colloidal drug carrier that exhibits greater stability compared to block copolymer micelles, i.e. polymeric nanoparticles. The main objective of this project was to develop polymeric nanoparticles for the parenteral delivery of hydrophobic anticancer drugs. The nanoparticles had to meet certain requirements such as be able to encapsulate hydrophobic anticancer drugs and release them in a controlled fashion over several days. Furthermore, the nanoparticles should confer prolonged plasma residence times to the encapsulated drug and favour its passive accumulation at its intended site of action, i.e. the tumour. The first part of this work focussed on applying PVP-b-PDLLA for the first time as polymeric emulsifier for the preparation of PDLLA nanoparticles with appropriate mean diameters (250 nm) using an oil-in-water emulsion method. Two hydrophobic anticancer drugs, PTX and etoposide (ETO), were successfully incorporated into the nanoparticles. A salting-out method was applied to enhance the loading efficiency of ETO, which was initially low given its slightly higher aqueous solubility compared to PTX. Both drugs were released in a controlled fashion from the PDLLA nanoparticles in vitro. Because of the lyoprotective effect of PVP, the polymer corona allowed for the particles to be easily redispersed in aqueous media following lyophilisation. The second part of the thesis aimed at evaluating whether the PVP coating could confer “stealth” properties to the PDLLA nanoparticles. Our study provided direct comparison between PVP and PEG, the most widely employed surface agent in drug delivery. In vitro protein adsorption and phagocytosis studies corroborated the in vivo findings, which showed that PVP-coated nanoparticles were rapidly cleared from circulation following their uptake by the mononuclear phagocyte system. Hence, our results indicated that PVP as coating materiel is not as efficient as PEG in conferring “stealth” properties to polymeric nanoparticles. Consequently, in the last section of this thesis, PEG was selected as coating agent while various biodegradable polymers were investigated as core-forming materials. Both synthetic (PDLLA and lactide/glycolide copolymers) and natural (polyhydroxyalkanoates (PHAs)) polyesters were tested. Our results demonstrated that the physicochemical properties of the polyesters significantly influenced the loading efficiency and release kinetics of PTX. While nanoparticles based on synthetic polyesters exhibited high encapsulation levels and controlled PTX release in vitro, PHA-based nanoparticles exhibited immediate unloading of their cargo. Pharmacokinetic and biodistribution studies in rodents revealed that encapsulating PTX in PEG-coated PDLLA-based nanoparticles led to enhanced plasma residence time and tumour deposition of the drug compared to Taxol®. Polymeric nanoparticles thus represent an appealing alternative to Taxol®.

This study was undertaken to characterize the role and pathway for assimilation of the intracellular carbon storage compound, poly-beta-hydroxybutyrate (PHB), in Rhizobium (Sinorhizobium) meliloti. Mutants unable to utilize the degradation intermediates, 3-hydroxybutyrate (HB) and/or acetoacetate (AA) were characterized. A mutant unable to utilize HB (Hbu-) while retaining the ability to utilize AA was found to be deficient in 3-hydroxybutyrate dehydrogenase (Bdh) activity. The bdhA mutant showed no symbiotic defects in association with alfalfa plants. However, when co-inoculated with the wild type, the mutant showed significantly reduced competitiveness. A more severe competition defect was observed for a PHB synthesis mutant (phaC). Both these mutants also showed reduced competitiveness when subjected to multiple cycles of subculturing through alternating carbon-rich and carbon-poor media, with the phaC mutant showing a greater loss in competitiveness. The results indicate that the ability to efficiently deposit and utilize cellular PHB stores is a key factor influencing competitive survival under conditions of fluctuating nutrient carbon availability. / The gene encoding Bdh (bdhA) was isolated and sequenced. Two transcription start sites, S1 and S2 were identified but no known consensus promoter sequences were identified upstream of either start site. A sigma 54 consensus binding sequence was found to be located between S1 and S2 but no corresponding transcript was detected. Transcriptional bdhA-lacZ fusion studies indicated that gene expression was growth-phase associated. The bdhA gene from Rhizobium sp. NGR234 was also isolated and characterized and found to be highly homologous to the R. meliloti bdhA sequence. Unlike R. meliloti , NGR234 is able to accumulate PHB during symbiosis. An NGR234 bdhA mutant showed symbiotic defects on Leucaena but not on Tephrosia, Macroptilium or Vigna host plants, indicating that the phenotype was host-dependent. / Mutations that suppress the Hbu- phenotype without restoring Bdh activity were identified, indicating the existence of a Bdh-independent pathway for HB utilization. These mutations mapped to the age-1 locus, which causes enhanced growth rate on HB and AA minimal media. Introduction of plasmid-borne multiple copies of a gene encoding acetoacetyl-CoA synthetase (acsA) into the bdhA mutant also results in suppression of the Hbu- phenotype. A possible mechanism of suppression involving direct activation of HB to 3-hydroxybutyryl-CoA, followed by reduction to acetoacetyl-CoA by the NADP-acetoacetyl-CoA reductase (encoded by phaB) was investigated. A strain carrying the triple mutations, age-1::Tn5-Tp, bdhA ::Tn5 and phaB::OSmSp retained the ability to utilize HB, indicating that the bypass mechanism does not involve NADP-acetoacetyl-CoA reductase. / The phaB mutant does not accumulate PHB or utilize HB or AA. Furthermore, colonies of the phaB and phaC mutants exhibit non-mucoid phenotype on yeast extract mannitol agar. The observation that a R. meliloti exoS null mutant is also Hbu- provides further support for a link between PHB and exopolysaccharide synthesis. Since ExoS is a positive regulator of succinoglycan biosynthesis it is hypothesized that regulation of succinoglycan synthesis by ExoS requires PHB synthesis.

<p>In this thesis, I present the electrochemical studies of three dendrimeric polypropylene imine (PPI) nanomaterials and their applications as a platform in the development of a novel label free DNA nanobiosensor based on electrochemical impedance spectroscopy. Cyclic voltammetry (CV), differentia pulse voltammetry (DPV), square wave voltammetry (SWV) and electrochemical impedance spectroscopy (EIS) techniques were used to study and model the electrochemical reactivities of the nanomaterials on glassy carbon electrode (GCE) as the working electrode.</p>

La préparation de formulations à libération contrôlée est le domaine des sciences pharmaceutiques qui vise à modifier l’environnement immédiat des principes actifs pour en améliorer l’efficacité et l’innocuité. Cet objectif peut être atteint en modifiant la cinétique de circulation dans le sang ou la distribution dans l’organisme. Le but de ce projet de recherche était d’étudier le profil pharmacocinétique (PK) de différentes formulations liposomales. L’analyse PK, généralement employée pour représenter et prédire les concentrations plasmatiques des médicaments et de leurs métabolites, a été utilisée ici pour caractériser in vivo des formulations sensibles au pH servant à modifier la distribution intracellulaire de principes actifs ainsi que des liposomes destinés au traitement des intoxications médicamenteuses. Dans un premier temps, la PK d’un copolymère sensible au pH, à base de N-isopropylacrylamide (NIPAM) et d’acide méthacrylique (MAA) a été étudiée. Ce dernier, le p(NIPAM-co-MAA) est utilisé dans notre laboratoire pour la fabrication de liposomes sensibles au pH. L’étude de PK conduite sur les profils de concentrations sanguines de différents polymères a défini les caractéristiques influençant la circulation des macromolécules dans l’organisme. La taille des molécules, leur point de trouble ainsi que la présence d’un segment hydrophobe à l’extrémité des chaînes se sont avérés déterminants. Le seuil de filtration glomérulaire du polymère a été évalué à 32 000 g/mol. Finalement, l’analyse PK a permis de s’assurer que les complexes formés par la fixation du polymère à la surface des liposomes restaient stables dans le sang, après injection par voie intraveineuse. Ces données ont établi qu’il était possible de synthétiser un polymère pouvant être adéquatement éliminé par filtration rénale et que les liposomes sensibles au pH préparés avec celui-ci demeuraient intacts dans l’organisme. En second lieu, l’analyse PK a été utilisée dans le développement de liposomes possédant un gradient de pH transmembranaire pour le traitement des intoxications médicamenteuses. Une formulation a été développée et optimisée in vitro pour capturer un médicament modèle, le diltiazem (DTZ). La formulation liposomale s’est avérée 40 fois plus performante que les émulsions lipidiques utilisées en clinique. L’analyse PK des liposomes a permis de confirmer la stabilité de la formulation in vivo et d’analyser l’influence des liposomes sur la circulation plasmatique du DTZ et de son principal métabolite, le desacétyldiltiazem (DAD). Il a été démontré que les liposomes étaient capables de capturer et de séquestrer le principe actif dans la circulation sanguine lorsque celui-ci était administré, par la voie intraveineuse. L’injection des liposomes 2 minutes avant l’administration du DTZ augmentait significativement l’aire sous la courbe du DTZ et du DAD tout en diminuant leur clairance plasmatique et leur volume de distribution. L’effet de ces modifications PK sur l’activité pharmacologique du médicament a ensuite été évalué. Les liposomes ont diminué l’effet hypotenseur du principe actif administré en bolus ou en perfusion sur une période d’une heure. Au cours de ces travaux, l’analyse PK a servi à établir la preuve de concept que des liposomes possédant un gradient de pH transmembranaire pouvaient modifier la PK d’un médicament cardiovasculaire et en diminuer l’activité pharmacologique. Ces résultats serviront de base pour le développement de la formulation destinée au traitement des intoxications médicamenteuses. Ce travail souligne la pertinence d’utiliser l’analyse PK dans la mise au point de vecteurs pharmaceutiques destinés à des applications variées. À ce stade de développement, l’aspect prédictif de l’analyse n’a pas été exploité, mais le côté descriptif a permis de comparer adéquatement diverses formulations et de tirer des conclusions pertinentes quant à leur devenir dans l’organisme. / Drug delivery is the field of pharmaceutical sciences which focuses on altering the immediate environment of drug molecules to improve their efficacy and safety. Drug delivery systems can potentiate the effect of active principles or alleviate their side effects by modifying their circulation profiles and/or biodistribution. The objective of this research project was to investigate the role of pharmacokinetic (PK) analysis in the development of novel drug delivery systems. PK analysis is generally applied to describe and predict the blood concentration profiles of low molecular weight drugs and their metabolites. Nevertheless, it is herein used to characterize the circulation of 2 liposomal formulations: pH-sensitive liposomes designed to alter the intracellular distribution of drugs and liposomes with transmembrane pH gradient for drug detoxification. The first series of experiments were designed to study the circulation kinetics of a pH-sensitive polymer prepared with N-isopropylacrylamide (NIPAM) and methacrylic acid (MAA). The copolymer p(NIPAM-co-MAA) is used in our laboratory to prepare serum-stable, PEGylated, pH-sensitive liposomes. The circulation profiles of polymers with different characteristics were characterized. The parameters which impacted the fate of the macromolecules were the length of the polymer chain, its cloud point and the presence of a hydrophobic anchor at one extremity of the molecule. The glomerular filtration cut-off of the polymer was determined to be around 32,000 g/mol. PK analysis allowed to conclude that the complexes prepared by anchoring the polymer on the surface of the liposomes remained stable in the bloodstream. This data established that pH-sensitive vesicular formulations could be produced using a polymer which could be excreted through renal filtration. It also confirmed that the formulation remained intact in the bloodstream. The second part of this work involved the development of liposomes with a transmembrane pH gradient designed to treat cardiovascular drug intoxications. Liposomes were designed and optimized in vitro to capture a model cardiovascular drug, diltiazem (DTZ). In vitro, the liposome uptake capacity was 40-fold higher than the lipid emulsion used in the clinic. PK analysis was used to verify the stability of the formulation in vivo, and to assess the impact of the liposomes on the plasma concentration of DTZ and its principal active metabolite, deacetyl-diltiazem (DAD). It was shown that the vesicles were able to capture and sequester DTZ and DAD. Injection of liposomes 2 min prior to administration of DTZ significantly increased the area under the plasma-concentration vs. time curve of both DTZ and DAD, while lowering their clearance and volume of distribution. The impact of the changes in PK on the pharmacological effect of the drug was also investigated. Liposomes tempered the hypotensive effect of the drug when the latter was administered via an intravenous bolus or a 1-h perfusion. Throughout this work, PK analysis proved to be an efficient tool to study the ability of transmembrane pH gradient liposomes to alter the blood circulation profiles of a cardiovascular drug, and to reduce its pharmacological effect. This proof of concept establishes firm ground for the further development of this colloidal formulation to treat drug intoxications. This work pointed out the relevance of PK analysis for the development of multi-purpose, colloidal drug delivery systems. At this stage, the predictive nature of the analysis was not exploited, but its descriptive properties allowed objective comparison of the circulation profiles of distinct systems and pertinent conclusions concerning their fate in vivo.

Thèse numérisée par la Division de la gestion de documents et des archives de l'Université de Montréal

Mémoire numérisé par la Division de la gestion de documents et des archives de l'Université de Montréal